Tolerability in Patients with Multiple Myeloma Treated with Daratumumab: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials

被引：1
|
作者：
Htut, Thura Win [1 ]
Win, Myint Aung [2 ]
Swarup, Sriman [3 ]
Sultan, Anita [3 ]
Adhikari, Nimesh [4 ]
Phyu, Ei Moe [2 ]
Dash, Akshar [4 ]
Han, Myat Min [5 ]
Myat, Yin Mon [6 ]
Awasthi, Sanjay [7 ]
Tijani, Lukman [8 ]
D'Cunha, Nicholas [9 ]
Quick, Donald P. [10 ]
Thein, Kyaw Zin [11 ]
机构：
[1] Aberdeen Royal Infirm Hosp, Dept Hematol, Aberdeen, Scotland
[2] LewisGale Med Ctr, Internal Med, Salem, VA USA
[3] Texas Tech Univ, Hlth Sci Ctr, Southwest Canc Ctr, Lubbock, TX 79430 USA
[4] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA
[5] Univ Texas MD Anderson Canc Ctr, Emergency Dept, Houston, TX 77030 USA
[6] Univ Coll Dublin, Dublin, Ireland
[7] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Hematol Oncol, Lubbock, TX 79430 USA
[8] Texas Tech Univ, Hlth Sci Ctr, Dept Hematol Oncol, Lubbock, TX 79430 USA
[9] Texas Tech Univ, Hlth Sci Ctr, Hematol Oncol, Lubbock, TX 79430 USA
[10] Joe Arrington Canc Res Treatment Ctr, Lubbock, TX USA
[11] Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX 77030 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-123164
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1873
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Daratumumab-Related Pulmonary Toxicities in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
    Win, Myint
    Thein, Kyaw
    Phyu, Ei
    Han, Myat
    D'Cunha, Paul
    Nelson, Joseph, III
    Quick, Donald
    Sklar, Allan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S242 - S242
  • [2] Risk of pneumonia and tolerability in patients with multiple myeloma treated with daratumumab: a systematic review and combined meta- analysis of six phase III randomised controlled trials
    Htut, T. W.
    Thein, K. Z.
    Win, M. A.
    Phyu, E. M.
    Lawrie, A.
    Tighe, J.
    Preston, G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 118 - 119
  • [3] A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of Hematological Toxicities in Patients with Multiple Myeloma Treated with Daratumumab
    Win, Myint
    Thein, Kyaw
    Phyu, Ei
    Han, Myat
    D'Cunha, Nicholas
    Tijani, Lukman
    Currie, Mark
    Quick, Donald
    Pendergrast, Kenneth
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S242 - S243
  • [4] Incidence and risks of pneumonia in patients with multiple myeloma treated with daratumumab: A systematic review and meta-analysis of randomized controlled trials.
    Tun, Aung
    Ticona, Katy
    Thein, Kyaw Zin
    Patel, Poras
    Zarubin, Vadim
    Guevara, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Tolerability, Incidence of Second Primary Skin Malignancies and Diarrhea in Patients with Relapsed Refractory Multiple Myeloma Treated with Isatuximab: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
    Htut, Thura Win
    Han, Myat Min
    Myat, Yin Mon
    Thein, Kyaw Zin
    BLOOD, 2023, 142
  • [6] Updated Meta-Analysis of Randomized Controlled Trials to Evaluate the Incidence of Infection and Pneumonia in Patients with Multiple Myeloma Treated with Daratumumab
    Htut, Thura Win
    Tun, Aung M.
    Sultan, Anita
    Win, Myint Aung
    Swarup, Sriman
    Phyu, Ei Moe
    Hlaing, Pwint Phyu
    Han, Myat Min
    Myat, Yin Mon
    Hardwicke, Fred
    Quick, Donald P.
    D'Cunha, Nicholas
    Tijani, Lukman
    Thein, Kyaw Zin
    BLOOD, 2019, 134
  • [7] Efficacy of Isatuximab Combination Regimens in Patients with Relapsed and Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
    Htut, Thura Win
    Phyu, Ei Moe
    Win, Myint Aung
    Thein, Kyaw Zin
    BLOOD, 2023, 142
  • [8] Systematic review and meta-analysis of randomized controlled trials of erythropoietin in multiple myeloma.
    Soares, HP
    Kumar, A
    Silvestri, F
    Djulbegovic, B
    BLOOD, 2004, 104 (11) : 70A - 70A
  • [9] Lenalidomide Treatment for Multiple Myeloma: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Yang, Bo
    Yu, Rui-li
    Chi, Xiao-hua
    Lu, Xue-chun
    PLOS ONE, 2013, 8 (05):
  • [10] Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
    Zeng, Zhiyong
    Lin, Junfang
    Chen, Junmin
    ANNALS OF HEMATOLOGY, 2013, 92 (07) : 935 - 943
12345